Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1978 7
1979 5
1980 8
1981 13
1982 10
1983 10
1984 14
1985 15
1986 12
1987 21
1988 14
1989 29
1990 26
1991 22
1992 23
1993 22
1994 23
1995 21
1996 20
1997 20
1998 18
1999 19
2000 21
2001 21
2002 18
2003 22
2004 19
2005 23
2006 19
2007 18
2008 14
2009 22
2010 23
2011 36
2012 39
2013 25
2014 44
2015 35
2016 35
2017 27
2018 29
2019 34
2020 27
2021 19
2022 12
2023 8
2024 6
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

898 results

Results by year

Filters applied: . Clear all
Page 1
[Self-medication].
Sailler L, Pugnet G, Montastruc JL. Sailler L, et al. Among authors: montastruc jl. Rev Prat. 2012 Dec;62(10):1463-7. Rev Prat. 2012. PMID: 23424934 Review. French. No abstract available.
Pharmacoepidemiology, the new paradigm of drug evaluation.
Bégaud B, Montastruc JL. Bégaud B, et al. Among authors: montastruc jl. Therapie. 2019 Apr;74(2):167-168. doi: 10.1016/j.therap.2018.12.009. Epub 2019 Jan 16. Therapie. 2019. PMID: 30686638 No abstract available.
Adverse drug reactions and ivermectin in COVID-19.
Montastruc JL. Montastruc JL. Therapie. 2022 Nov-Dec;77(6):633-634. doi: 10.1016/j.therap.2022.04.003. Epub 2022 Apr 27. Therapie. 2022. PMID: 35599192 Free PMC article. No abstract available.
[Drug-induced parkinson syndromes].
Nguyen N, Pradel V, Micallef J, Montastruc JL, Blin O. Nguyen N, et al. Among authors: montastruc jl. Therapie. 2004 Jan-Feb;59(1):105-12. doi: 10.2515/therapie:2004021. Therapie. 2004. PMID: 15199676 Review. French.
Atropinic (Anticholinergic) Burden in Parkinson's Disease.
De Germay S, Montastruc JL, Rousseau V, Chebane L, Bondon-Guitton E, Moulis F, Durrieu G, Bagheri H, Rascol O, Pariente A, Bégaud B, Montastruc F. De Germay S, et al. Among authors: montastruc jl. Mov Disord. 2016 May;31(5):632-6. doi: 10.1002/mds.26595. Epub 2016 Mar 29. Mov Disord. 2016. PMID: 27028036 Review.
Drug-induced parkinsonism: a review.
Montastruc JL, Llau ME, Rascol O, Senard JM. Montastruc JL, et al. Fundam Clin Pharmacol. 1994;8(4):293-306. doi: 10.1111/j.1472-8206.1994.tb00808.x. Fundam Clin Pharmacol. 1994. PMID: 7851836 Review.
[Atropine].
Montastruc JL, Tran MA. Montastruc JL, et al. Rev Prat. 1998 Jan 1;48(1):85-7. Rev Prat. 1998. PMID: 9781216 French. No abstract available.
Pharmacovigilance: The new challenges.
Bagheri H, Laroche ML, Montastruc JL. Bagheri H, et al. Among authors: montastruc jl. Therapie. 2016 Apr;71(2):121-2. doi: 10.1016/j.therap.2016.02.019. Epub 2016 Feb 10. Therapie. 2016. PMID: 27080828 English, French. No abstract available.
Biosimilaires : de la technique au médicoéconomique.
Girault D, Trouvin JH, Blachier-Poisson C, Gary F, Laloye D; et les participants à la table ronde N°3 de Giens XXX :; Bergmann JF, Casadevall N, Delval C, De Sahb Berkovitch R, Fagon JY, Gersberg M, Lassale C, Lechat P, Le Jeunne C, Montastruc JL, Prugnaud JL, Ratignier-Carbonneil C, Rey-Coquais C. Girault D, et al. Among authors: montastruc jl. Therapie. 2015 Jan-Feb;70(1):37-46. doi: 10.2515/therapie/2014233. Therapie. 2015. PMID: 27393395 French. No abstract available.
898 results